Three million kronor for research on mast cells in asthma

Gunnar Pejler at Uppsala University has received three million kronor from Hjärt-Lungfonden to investigate how old drugs can be used against asthma.

Gunnar Pejler, professor of immunology at Uppsala University, will now deepen his work on drugs that can cause mast cells to break down. The goal is to prevent asthma attacks by stopping inflammation before it reaches the airways.

– We have already seen that certain existing drugs can cause mast cells to break down, which can prevent asthma attacks and ultimately save lives, says Pejler.

Asthma is one of Sweden's most common chronic diseases and affects both children and adults. The research aims to provide more knowledge about how mast cells affect other cells in the lungs.

Jannice Andersson, who has lived with asthma since her teens, takes medication six to eight times a day. She hopes the new research can make daily life easier for people with the disease.

관련 기사

A doctor giving an injection to a patient in a clinic with brain scans in the background, illustrating a trial on immune drug for depression.
AI에 의해 생성된 이미지

Small JAMA Psychiatry trial suggests immune-targeting drug may help some treatment-resistant depression symptoms

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

A proof-of-concept randomized clinical trial published online May 20, 2026, in JAMA Psychiatry found signals that tocilizumab—an anti-inflammatory drug used for immune-mediated conditions including rheumatoid arthritis—may improve some symptoms in adults with moderate-to-severe depression who had a poor response to antidepressants and evidence of low-grade inflammation.

The government has decided to broaden an investigation into the international pharmaceutical market following reports of shortages in estrogen medications.

AI에 의해 보고됨

A study in mice suggests that blocking a specific receptor can restore the body's ability to clear senescent cells, leading to healthier aging outcomes including better memory and reduced frailty.

Researchers have identified a rare genetic mutation that may help people from long-lived families stay healthier longer by reducing harmful inflammation. The findings were presented at the European Society of Human Genetics conference in Gothenburg.

AI에 의해 보고됨

Berndt-Rune Jäverbrant from Rättvik urges people with chronic illnesses to renew prescriptions well in advance.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부